Beta-Blockade, Chronotropic Incompetence, and a Target Heart Rate

The calculation: 0.70 × 163 = 114 bpm.

Why it fails: he reached only 92 bpm at maximal, symptom-limited effort (RPE 15). A 114 bpm target is above his entire tested range - it would prescribe an intensity he never achieved during a maximal test, and any attempt to reach it would be effort beyond his peak, not moderate intensity.

Contributing factors:

• Carvedilol blunts the heart rate response and flattens the slope of HR versus workload; age-based formulas assume an unmedicated slope.
• Chronotropic incompetence is common in HFrEF and is suggested by a peak HR of 92 at maximal effort.
• The percentage-of-max formula also ignores resting HR, which is why reserve-based methods are preferred in general - but even HR reserve is compressed here.

His own reserve: HRR = 92 − 58 = 34 bpm. 40–60% HRR gives 58 + 0.40(34) to 58 + 0.60(34) = 72–78 bpm; 70% HRR gives about 82 bpm. That range is narrow and sits close to his resting rate, so heart rate alone is a poor control dial.

Answer to him: "Your medication keeps your heart rate low on purpose. That is good for your heart, but it makes the standard formula wrong for you. We will use effort, breathing, and workload instead, and treat your watch as a ceiling, not a target."

Mode: walking and stationary cycling; add light-to-moderate resistance training after 2–3 weeks of tolerated aerobic work.

Frequency: 3–5 days per week, with supervised sessions 2–3 times weekly initially.

Intensity:

• Primary anchors: RPE 11–13 (fairly light to somewhat hard), talk test permitting short sentences, dyspnea 3–4 on a 0–10 scale.
• Workload equivalent: approximately 55–70% of his peak 5.2 METs, i.e., about 3.0–3.6 METs on the cycle or a comfortable walking pace.
• HR as a safety ceiling of roughly 80–85 bpm initially, not as a target to chase. If HR exceeds the ceiling with low RPE, that is data to report, not a reason to stop automatically.

Duration: 20–30 minutes total, using intervals if needed (e.g., 3 minutes work/1 minute active recovery), progressing to 30–40 minutes continuous. Include 5–10 minutes warm-up and cool-down.

Supervision: ECG-monitored sessions early, with a provider present; transition to telemetry spot checks as tolerance is demonstrated.

Progression: increase duration before intensity; advance roughly every 1–2 weeks if there is no dyspnea at rest, no weight gain >2 kg in 3 days, no new edema, no arrhythmia, and RPE remains ≤13. Resistance: 1–2 sets of 10–12 repetitions at RPE 12–13, avoiding Valsalva.

Stop rules: chest pain, dizziness, palpitations, unusual dyspnea, SpO2 <88%, or a rate that will not settle with rest.

Reassuring features:

• Peak workload 5.2 METs is a meaningful functional capacity and supports a good prognosis in HFrEF.
• Appropriate BP rise (104/66 to 128/72) without hypotension or an exaggerated response.
• No arrhythmia and no ischemic ECG changes at peak.
• SpO2 96% at peak with no desaturation.
• He stopped at RPE 15, consistent with a genuine symptom-limited test rather than a submaximal effort.

Teaching him to use the watch:

1. "The number on your wrist is a speedometer warning light, not a cruise control. If it reads above about 85, slow down and check your breathing and effort rather than trying to hit a number."
2. Use the talk test: he should be able to speak in short sentences but not sing.
3. Use RPE 11–13 as the daily target and note it after each session in a simple log.
4. Watch for red flags: dyspnea that persists after 5 minutes of rest, dizziness, palpitations, chest pain, or a resting weight gain of 2 kg in 3 days.
5. Check the watch against how he feels - if the value and the sensation disagree, trust the sensation and report the discrepancy.

Reasoning: with blunted chronotropy, the prescription must be effort-anchored and the technology demoted to a safety aid. That framing also protects him from over-exercising to hit an arbitrary number.